Pancreatic Cancer

Overview

Pancreatic cancer is a serious disease in which malignant cells form in the tissues of the pancreas, an organ located behind the stomach that plays a vital role in digestion and blood sugar regulation. It is the fourth leading cause of cancer death in the United States, known for its aggressive nature and often late diagnosis.

The pancreas has two main functions: exocrine function (producing enzymes for digestion) and endocrine function (producing hormones like insulin). Most pancreatic cancers (about 95%) arise from the exocrine cells and are called pancreatic adenocarcinomas. The remaining 5% develop from the hormone-producing cells and are called pancreatic neuroendocrine tumors.

Pancreatic cancer is particularly challenging because it often doesn't cause symptoms until it has spread to other organs. The pancreas is located deep in the abdomen, making early tumors difficult to detect during routine physical examinations. When symptoms do appear, they're often vague and can be attributed to many other conditions, leading to delays in diagnosis.

Despite these challenges, advances in surgical techniques, chemotherapy regimens, and targeted therapies have improved outcomes for some patients. Early detection remains crucial, as the 5-year survival rate for localized pancreatic cancer is about 39%, compared to just 3% for distant-stage disease.

Symptoms

Pancreatic cancer symptoms often don't appear until the disease is advanced. When they do occur, symptoms may be subtle and gradually worsen over time. The location of the tumor within the pancreas can influence which symptoms appear first.

Additional Symptoms

• Light-colored or greasy stools (steatorrhea)
• Dark urine
• Itchy skin (often associated with jaundice)
• Blood clots (deep vein thrombosis or pulmonary embolism)
• Loss of appetite
• Depression (sometimes appears before physical symptoms)

Causes

The exact cause of pancreatic cancer is not fully understood, but researchers have identified how certain changes in pancreatic cell DNA lead to uncontrolled cell growth and tumor formation.

Genetic Mutations

Pancreatic cancer develops when cells in the pancreas acquire mutations in their DNA. These mutations can be:

• Acquired mutations: Most pancreatic cancers result from DNA changes that occur during a person's lifetime, often due to environmental factors or random cellular errors
• Inherited mutations: About 10% of pancreatic cancers are hereditary, caused by genetic mutations passed from parents to children

Key Genetic Changes

Several genes are commonly mutated in pancreatic cancer:

• KRAS: Mutated in about 90% of pancreatic cancers
• CDKN2A/p16: Inactivated in about 95% of cases
• TP53: Mutated in 50-75% of cases
• SMAD4: Lost in about 55% of cases

Contributing Factors

Various factors can damage DNA and contribute to pancreatic cancer development:

• Chronic inflammation of the pancreas
• Exposure to carcinogenic chemicals (tobacco smoke, certain pesticides)
• Metabolic factors (obesity, diabetes)
• Age-related cellular changes

Risk Factors

Several factors can increase the risk of developing pancreatic cancer. Having one or more risk factors doesn't mean you will develop the disease, but awareness can help with prevention and early detection strategies.

Medical Conditions

Certain medical conditions are associated with increased pancreatic cancer risk:

• Chronic pancreatitis: Long-term inflammation of the pancreas
• Diabetes: Long-standing diabetes increases risk; new-onset diabetes may be an early sign
• Pancreatic cysts: Some types may progress to cancer
• Stomach infection with H. pylori: May slightly increase risk
• Hepatitis B infection: Associated with increased risk

Types of Pancreatic Cancer

Pancreatic cancers are classified based on the type of cell they start in and their behavior:

Exocrine Tumors (95% of cases)

• Pancreatic adenocarcinoma: The most common type, accounting for about 90% of all pancreatic cancers. Starts in the ducts of the pancreas
• Acinar cell carcinoma: Rare, accounting for 1-2% of exocrine cancers
• Adenosquamous carcinoma: Very rare and tends to be more aggressive
• Colloid carcinoma: Tends to have a better prognosis than typical adenocarcinoma

Pancreatic Neuroendocrine Tumors (PNETs) (5% of cases)

• Functional PNETs: Produce hormones causing specific symptoms
  • Insulinomas (produce insulin)
  • Gastrinomas (produce gastrin)
  • Glucagonomas (produce glucagon)
  • Somatostatinomas (produce somatostatin)
  • VIPomas (produce vasoactive intestinal peptide)
• Non-functional PNETs: Don't produce hormones, often diagnosed later

Precancerous Lesions

• Intraductal papillary mucinous neoplasms (IPMNs): Cystic tumors that may become cancerous
• Mucinous cystic neoplasms (MCNs): Almost always occur in women, can progress to cancer
• Pancreatic intraepithelial neoplasia (PanIN): Microscopic changes in duct cells

Diagnosis

Diagnosing pancreatic cancer often requires multiple tests to confirm the presence of cancer, determine its type, and assess its extent.

Initial Evaluation

• Medical history and physical exam: Assessment of symptoms, risk factors, and physical signs
• Blood tests:
  • Liver function tests
  • Bilirubin levels
  • CA 19-9 tumor marker (not diagnostic alone)
  • CEA levels

Imaging Tests

1. CT scan with contrast: The primary imaging tool for diagnosis and staging
2. MRI/MRCP: Provides detailed images of the pancreas and bile ducts
3. Endoscopic ultrasound (EUS): Highly sensitive for detecting small tumors
4. PET scan: Helps detect metastases
5. ERCP: Can visualize and biopsy the pancreatic duct

Tissue Diagnosis

Definitive diagnosis requires tissue examination:

• Fine-needle aspiration (FNA): Usually guided by EUS or CT
• Core needle biopsy: Provides more tissue for analysis
• Brush cytology: During ERCP
• Laparoscopy: May be used to assess spread before surgery

Molecular Testing

For advanced cancers, testing may include:

• Microsatellite instability (MSI) testing
• Mismatch repair (MMR) deficiency testing
• BRCA mutation testing
• Other targetable mutations

Staging

Staging determines the extent of cancer spread and guides treatment decisions. Pancreatic cancer uses the TNM system and is also classified by resectability.

Treatment Options

Treatment depends on the cancer's stage, location, and the patient's overall health. A multidisciplinary team approach is essential for optimal care.

Surgery

For resectable tumors (15-20% of cases):

• Whipple procedure (pancreaticoduodenectomy): For tumors in the head of the pancreas. Removes the head of the pancreas, part of the small intestine, gallbladder, and part of the bile duct
• Distal pancreatectomy: For tumors in the body or tail. Removes the left part of the pancreas, often with the spleen
• Total pancreatectomy: Removes the entire pancreas, gallbladder, spleen, and part of the stomach and small intestine

Chemotherapy

Radiation Therapy

• External beam radiation: Often combined with chemotherapy
• Stereotactic body radiation (SBRT): Precise, high-dose radiation
• Proton therapy: May reduce damage to surrounding organs

Targeted Therapy and Immunotherapy

• PARP inhibitors: For patients with BRCA mutations
• Erlotinib: EGFR inhibitor sometimes added to gemcitabine
• Pembrolizumab: For MSI-high or MMR-deficient tumors
• Larotrectinib or entrectinib: For NTRK fusion-positive tumors

Supportive Care

• Pain management: Nerve blocks, medications
• Nutritional support: Pancreatic enzyme replacement
• Biliary stenting: For bile duct obstruction
• Blood sugar control: For diabetes management

Prognosis

Pancreatic cancer has one of the lowest survival rates among major cancers, but outcomes vary significantly based on stage at diagnosis and treatment response.

Survival Statistics

• Overall 5-year survival rate: About 11%
• Localized disease: 39% 5-year survival
• Regional spread: 13% 5-year survival
• Distant metastases: 3% 5-year survival

Factors Affecting Prognosis

• Stage at diagnosis (most important factor)
• Tumor location and size
• Resectability of the tumor
• CA 19-9 levels
• Overall health and performance status
• Response to treatment
• Molecular characteristics of the tumor

Prevention

While not all cases of pancreatic cancer can be prevented, several strategies can reduce risk:

Lifestyle Modifications

• Don't smoke: Quitting smoking at any age reduces risk
• Maintain healthy weight: Especially important to avoid abdominal obesity
• Limit alcohol: Heavy drinking increases risk of chronic pancreatitis
• Healthy diet: Rich in fruits, vegetables, and whole grains; limited red meat
• Regular exercise: At least 150 minutes of moderate activity weekly

Medical Management

• Control diabetes: Proper management may reduce risk
• Treat chronic pancreatitis: Manage underlying causes
• Workplace safety: Limit exposure to certain chemicals

Screening for High-Risk Individuals

Consider screening if you have:

• Two or more first-degree relatives with pancreatic cancer
• Hereditary pancreatitis
• Known genetic mutations (BRCA2, PALB2, Lynch syndrome)
• Peutz-Jeghers syndrome

Screening typically involves annual MRI/MRCP or EUS starting at age 50 or 10 years before the youngest affected relative's diagnosis age.

When to See a Doctor

Early detection of pancreatic cancer is challenging but crucial. See your healthcare provider if you experience:

• Persistent abdominal or back pain
• Unexplained weight loss (more than 5% of body weight)
• New-onset diabetes, especially if over 50
• Jaundice (yellowing of skin and eyes)
• Changes in stool (light-colored, greasy, floating)
• Persistent nausea or vomiting
• Loss of appetite lasting more than two weeks

Related Conditions